Neurology2010CohortNeuroprotection

Cortexin in the complex treatment of post stroke epilepsy

Gafurov B.G., Gafurov Sh.B.

Not stated in the PubMed record

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova 110(3 Suppl 2): 88-90

Study Type
Cohort

Abstract

Article in Russian. 46 patients on standard medical care were examined; 29 also received Cortexin 10 mg intramuscularly for 15 days and 17 received standard care only. The authors report that adding Cortexin improved clinical results, reflected in EEG changes. Injectable prescription preparation; not a supplement study. Summary based on the PubMed abstract (PMID 20873481).

What the study did

Article in Russian. 46 patients on standard medical care were examined; 29 also received Cortexin 10 mg intramuscularly for 15 days and 17 received standard care only. The authors report that adding Cortexin improved clinical results, reflected in EEG changes. Injectable prescription preparation; not a supplement study.

Reading it honestly

This summary is based on the PubMed abstract (PMID 20873481). It describes research on the named preparation, not on any capsule product sold today, and it is not a claim that any product treats or prevents a disease.


Study Limitations

  • •Summary based on the PubMed abstract only
  • •Single research group; independent replication is limited
  • •Results concern the studied preparation, not any capsule product

Key Findings

  • ✓Small comparative clinical report
  • ✓EEG used as the outcome
  • ✓Injectable Cortexin, not a capsule

Mechanism of Action

Not studied.